HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
-6.86%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$166M
AUM Growth
+$166M
(+5.3%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
15.39%
Top 10 Holdings %
Top 10 Hldgs %
40.91%
Holding
125
New
39
Increased
43
Reduced
18
Closed
15
Top Buys
| 1 |
Mastercard
MA
|
$4.04M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$3.45M |
| 3 |
TEGNA Inc
TGNA
|
$3.02M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$2.39M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$2.23M |
Top Sells
| 1 |
PBCT
People's United Financial Inc
PBCT
|
$3.92M |
| 2 |
Fidelity National Information Services
FIS
|
$3.85M |
| 3 |
CERN
Cerner Corp
CERN
|
$3.49M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$1.5M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$979K |
Sector Composition
| 1 | Healthcare | 46.47% |
| 2 | Technology | 22.39% |
| 3 | Financials | 16.85% |
| 4 | Communication Services | 4.29% |
| 5 | Consumer Discretionary | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPARU
26
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
| $1.95M | 1.18% | 200,000 | – | – |
|
27
NovoCure
NVCR
$1.38B
| $1.95M | 1.17% | 28,007 +10,559 | +61% | +$734K |
|
28
Relay Therapeutics
RLAY
$619M
| $1.9M | 1.15% | 113,313 +44,705 | +65% | +$749K |
|
29
Arcus Biosciences
RCUS
$1.13B
| $1.82M | 1.1% | 71,650 +21,600 | +43% | +$547K |
|
30
IDEAYA Biosciences
IDYA
$2.15B
| $1.8M | 1.09% | 130,380 +80,853 | +163% | +$1.12M |
|
31
Biomea Fusion
BMEA
$116M
| $1.73M | 1.05% | 144,727 +31,809 | +28% | +$381K |
|
32
Dyne Therapeutics
DYN
$1.92B
| $1.66M | 1% | 241,867 +73,176 | +43% | +$503K |
|
33
Generation Bio
GBIO
$40.4M
| $1.63M | 0.99% | 248,994 +117,699 | +90% | +$772K |
|
|
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
| $1.17M | 0.7% | 395,332 +188,025 | +91% | +$555K |
|
35
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $1.13M | 0.68% | 42,396 | – | – |
|
36
Karyopharm Therapeutics
KPTI
$61.7M
| $1.13M | 0.68% | +250,377 | New | +$1.13M |
|
37
Microsoft
MSFT
$3.77T
| $1.02M | 0.62% | +3,988 | New | +$1.02M |
|
38
Amicus Therapeutics
FOLD
$2.34B
| $969K | 0.59% | 90,234 -18,023 | -17% | -$194K |
|
39
BridgeBio Pharma
BBIO
$9.89B
| $962K | 0.58% | 105,942 +20,642 | +24% | +$187K |
|
40
Merus
MRUS
$4.98B
| $916K | 0.55% | 40,481 +10,093 | +33% | +$228K |
|
|
KDNY
41
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $889K | 0.54% | 50,834 -16,943 | -25% | -$296K |
|
|
IMGN
42
DELISTED
Immunogen Inc
IMGN
| $863K | 0.52% | 191,726 +114,032 | +147% | +$513K |
|
43
Edgewise Therapeutics
EWTX
$1.51B
| $824K | 0.5% | 103,462 +43,729 | +73% | +$348K |
|
44
argenx
ARGX
$43.6B
| $816K | 0.49% | 2,153 -908 | -30% | -$344K |
|
45
United Therapeutics
UTHR
$13.8B
| $813K | 0.49% | 3,452 +795 | +30% | +$187K |
|
46
Beam Therapeutics
BEAM
$1.66B
| $812K | 0.49% | 20,980 +9,878 | +89% | +$382K |
|
47
Gossamer Bio
GOSS
$562M
| $810K | 0.49% | 96,795 +26,753 | +38% | +$224K |
|
48
Krystal Biotech
KRYS
$4.27B
| $803K | 0.48% | +12,225 | New | +$803K |
|
|
CERE
49
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $752K | 0.45% | +28,450 | New | +$752K |
|
|
AMRN
50
Amarin Corp
AMRN
$311M
| $746K | 0.45% | 500,680 +23,936 | +5% | +$35.7K |
|